The fact
This date is eagerly awaited by biopharmaceutical sector investors.
Genfit's performance, as Ipsen's partner, may be impacted.
Click the link to read an article on the topic:
This date is eagerly awaited by biopharmaceutical sector investors.
Genfit's performance, as Ipsen's partner, may be impacted.